Analystreport

Keryx Biopharmaceuticals (NASDAQ: KERX) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating.

KERYX BIOPHARMACEUTICALS  (KERX) 
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.keryx.com/investor-overview